[1] Hu B Y, Wan T, Zhang W Z, et al. Risk factors for postoperative pancreatic fistula:analysis of 539 successive cases of pancreaticoduodenectomy[J]. World J Gastroenterol, 2016, 22(34):7797-7805. [2] Yu L, Huang Q, Xie F, et al. Risk factors of postoperative complications of pancreatoduodenectomy[J]. Hepatogastroenterology, 2014, 61(135):2091-2095. [3] Bruns H, Kortendieck V, Raab H R, et al. Intraoperative fluid excess is a risk factor for pancreatic fistula after partial pancreaticoduodenectomy[J]. HPB Surg, 2016:2016, 1601340. [4] Wang S, Wang X, Dai H, et al. The effect of Intraoperative fluid volume administration on pancreatic fistulas after pancreaticoduodenectomy[J]. J Invest Surg, 2014, 27(2):88-94. [5] Bassi C, Marchegiani G, Dervenis C, et al. The 2016 update of the international study group(ISGPS) definition and grading of postoperative pancreatic fistula:11 Years After[J]. Surgery, 2017, 161(3):584-591. [6] Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula:an international study group(ISGPF) definition[J]. Surgery, 2005, 138(1):8-13. [7] Pratt W B, Maithel S K, Vanounou T, et al. Clinical and economic validation of the international study group of pancreatic fistula(ISGPF) classification scheme[J]. Ann Surg, 2007, 245(3):443-451. [8] Kim W S, Choi D W, Choi S H, et al. Clinical validation of the ISGPF classification and the risk factors of pancreatic fistula formation following duct-to-mucosa pancreaticojejunostomy by one surgeon at a single center[J]. J Gastrointest Surg, 2011, 15(12):2187-2192. [9] McMillan M T, Soi S, Asbun H J, et al. Risk-adjusted outcomes of clinically relevant pancreatic fistula following pancreatoduodenectomy:a model for performance evaluation[J]. Ann Surg, 2016, 264(2):344-352. [10] Bundgaard-Nielsen M, Secher N H, Kehlet H. ‘Liberal’ vs ‘restrictive’ perioperative fluid therapy-a critical assessment of the evidence[J]. Acta Anaesthesiol Scand, 2009, 53(7):843-851. [11] Chappell D, Jacob M, Hofmann-Kiefer K, et al. A rational approach to perioperative fluid management[J]. Anesthesiology, 2008, 109(4):723-740. [12] de Aguilar-Nascimento J E, Diniz B N, do Carmo A V, et al. Clinical benefits after the implementation of a protocol of restricted perioperative intravenous crystalloid fluids in major abdominal operations[J]. World J Surg, 2009, 33(5):925-930. [13] Pedrazzoli S. Pancreatoduodenectomy(PD) and postoperative pancreatic fistula(POPF):A systematic review and analysis of the POPF-related mortalityrate in 60,739 patients retrieved from the English literature published between 1990 and 2015[J]. Medicine(Baltimore), 2017, 96(19):e6858. [14] Nisanevich V, Felsenstein I, Almogy G, et al. Effect of intraoperative fluid management on outcome after intraabdominal surgery[J]. Anesthesiology, 2005, 103(1):25-32. [15] Jonsson K, Jensen J A, Goodson W H 3rd, et al. Tissue oxygenation, anemia, and perfusion in relation to wound healing in surgical patients[J]. Ann Surg, 1991, 214(5):605-613. [16] 李洁. 弹簧圈在胰十二指肠切除术后出血治疗中的临床应用[J].首都医科大学学报,2015,36(3):483-487. [17] 李可,杨艳.胰十二指肠切除术后胰瘘的防治进展[J].中国煤炭工业医学杂志,2015,18(12):2155-2160. |